Enliven Therapeutics Correlations

ELVN Stock

21.35 0.45 2.06%

The current 90-days correlation between Enliven Therapeutics and Cullinan Oncology LLC is -0.13 (i.e., Good diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enliven Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enliven Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Enliven Therapeutics Correlation With Market

Good diversification

The correlation between Enliven Therapeutics and DJI is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Enliven Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

To learn how to invest in Enliven Stock, please use our How to Invest in Enliven Therapeutics guide.

Moving together with Enliven Stock

0.81	FATE	Fate Therapeutics	Pair Corr
0.73	NVO	Novo Nordisk AS	Pair Corr
0.77	INZY	Inozyme Pharma	Pair Corr
0.71	KURA	Kura Oncology	Pair Corr
0.79	NTLA	Intellia Therapeutics	Pair Corr
0.78	REGN	Regeneron Pharmaceuticals	Pair Corr
0.85	ABOS	Acumen Pharmaceuticals	Pair Corr
0.84	ADTX	Aditxt Inc	Pair Corr
0.75	STRO	Sutro Biopharma	Pair Corr
0.82	TCRX	Tscan Therapeutics	Pair Corr
0.75	TERN	Terns Pharmaceuticals	Pair Corr

Moving against Enliven Stock

0.68	OPT	Opthea	Pair Corr
0.61	TMO	Thermo Fisher Scientific	Pair Corr
0.61	LTRN	Lantern Pharma	Pair Corr
0.59	VERV	Verve Therapeutics	Pair Corr
0.58	FENC	Fennec Pharmaceuticals	Pair Corr
0.56	PFE	Pfizer Inc Aggressive Push	Pair Corr
0.55	GANX	Gain Therapeutics	Pair Corr
0.52	A	Agilent Technologies Earnings Call Today	Pair Corr
0.52	WAT	Waters	Pair Corr
0.39	CUE	Cue Biopharma	Pair Corr
0.68	DBVT	DBV Technologies Earnings Call This Week	Pair Corr
0.66	PHGE	Biomx Inc	Pair Corr
0.56	CGTX	Cognition Therapeutics	Pair Corr
0.55	CPRX	Catalyst Pharmaceuticals Earnings Call Today	Pair Corr

Related Correlations Analysis

	THRX	PMVP	CGEM	IMRX	AVTE	MLTX	GPCR	CMPX	REPL	NVCT
THRX		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	THRX
PMVP	0.0		0.83	0.35	0.59	0.78	0.71	-0.76	-0.11	-0.65	PMVP
CGEM	0.0	0.83		0.55	0.79	0.88	0.82	-0.82	-0.2	-0.83	CGEM
IMRX	0.0	0.35	0.55		0.67	0.5	0.32	-0.43	-0.12	-0.36	IMRX
AVTE	0.0	0.59	0.79	0.67		0.75	0.7	-0.63	-0.12	-0.59	AVTE
MLTX	0.0	0.78	0.88	0.5	0.75		0.73	-0.84	-0.13	-0.83	MLTX
GPCR	0.0	0.71	0.82	0.32	0.7	0.73		-0.56	0.02	-0.68	GPCR
CMPX	0.0	-0.76	-0.82	-0.43	-0.63	-0.84	-0.56		0.48	0.85	CMPX
REPL	0.0	-0.11	-0.2	-0.12	-0.12	-0.13	0.02	0.48		0.44	REPL
NVCT	0.0	-0.65	-0.83	-0.36	-0.59	-0.83	-0.68	0.85	0.44		NVCT
	THRX	PMVP	CGEM	IMRX	AVTE	MLTX	GPCR	CMPX	REPL	NVCT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

MLTX	+ 0.88	CGEM
NVCT	+ 0.85	CMPX
CGEM	+ 0.83	PMVP
GPCR	+ 0.82	CGEM
AVTE	+ 0.79	CGEM
MLTX	+ 0.78	PMVP

High negative correlations

CMPX	- 0.84	MLTX
NVCT	- 0.83	MLTX
NVCT	- 0.83	CGEM
CMPX	- 0.82	CGEM
CMPX	- 0.76	PMVP
NVCT	- 0.68	GPCR

Risk-Adjusted Indicators

There is a big difference between Enliven Stock performing well and Enliven Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Enliven Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
THRX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PMVP	1.78	(0.16)	0.00	0.80	0.00	0.00	4.38	(3.31)	9.70
CGEM	2.48	(0.65)	0.00	(1.68)	0.00	0.00	4.98	(6.27)	15.27
IMRX	3.66	0.03	0.00	0.03	4.91	(4.36)	10.00	(7.77)	30.08
AVTE	1.45	(0.07)	0.00	(0.19)	0.00	0.00	4.30	(3.27)	10.45
MLTX	2.49	(0.23)	0.00	(2.03)	0.00	0.00	4.74	(5.44)	13.46
GPCR	3.31	(0.53)	0.00	(0.35)	0.00	0.00	6.75	(8.73)	22.52
CMPX	5.55	1.45	0.24	0.39	4.79	(6.29)	14.18	(8.88)	44.59
REPL	3.48	0.48	0.14	0.21	3.13	(4.42)	8.45	(5.88)	46.30
NVCT	3.31	0.70	0.18	(0.65)	3.46	(3.71)	7.96	(5.75)	25.78

Enliven Therapeutics Corporate Executives

Elected by the shareholders, the Enliven Therapeutics' board of directors comprises two types of representatives: Enliven Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Enliven. The board's role is to monitor Enliven Therapeutics' management team and ensure that shareholders' interests are well served. Enliven Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Enliven Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

Joseph Lyssikatos	CoFounder Officer	Profile
Benjamin Hohl	CFO Development	Profile
Anish PharmD	CoFounder COO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC